Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 46742
95 % 2 2 30727 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 32344
70 % 2 2 35895
50 % 2 2 25382
40 % 2 2 23123
30 % 27 40 1195
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 72320
95 % 1 1 44653
90 % 469 805 2
70 % 1528 2435 2
50 % 3880 6273 1
40 % 3880 6273 1
30 % 3908 6319 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 72319
95 % 1 1 59583
90 % 1 1 56169
70 % 1854 3001 1
50 % 3881 6273 1
40 % 3881 6273 1
30 % 3909 6319 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 72322
95 % 2 2 42977 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 38258
70 % 1855 3001 1
50 % 3882 6273 1
40 % 3882 6273 1
30 % 3910 6319 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 52635
95 % 132 232 68 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 0.9
PDBFlex
90 % 470 805 2
70 % 1529 2435 2
50 % 3883 6273 1
40 % 3883 6273 1
30 % 3911 6319 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 4P48 1 A Antibody scFv 180 9031
21 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
22 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
23 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
24 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
25 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
26 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
27 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
28 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
29 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
30 6MEE 2 B, D antibody HEPC74 Light Chain 9606
31 6BJZ 1 H 5c8 Fab Heavy chain 9606
32 6BJZ 2 L 5c8 Fab Light chain 9606
33 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
34 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
35 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
36 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
37 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
38 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
39 4XCF 1 L 4E10 Fab light chain 9606
40 4XCF 2 H 4E10 Fab heavy chain 9606
41 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
42 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
43 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
44 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
45 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
46 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
47 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
48 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
49 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
50 5X08 1 H Fab 4E10 Heavy chain 9606
51 5X08 2 L Fab 4E10 Light chain 9606
52 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
53 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
54 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
55 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
56 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
57 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
58 6MEG 1 H antibody HEPC46 Heavy Chain 9606
59 6MEG 2 L antibody HEPC46 Light Chain 9606
60 5C2B 1 H scFv 3B4 9606
61 6O3K 1 L PGZL1.H4K3 light chain 9606
62 6O3K 2 H PGZL1.H4K3 heavy chain 9606
63 4XAW 1 L 4E10 Fab light chain 9606
64 4XAW 2 H 4E10 Fab heavy chain 9606
65 4P49 1 A Antibody scFv B8 9031
66 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
67 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
68 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
69 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
70 5UCB 1 H Fab Heavy Chain 9606
71 5UCB 2 L Fab Light Chain 9606
72 2VXV 1 H HUMAN IGG ABT-325 9606
73 2VXV 2 L HUMAN IGG ABT-325 9606
74 6QF9 1 A, B scFv 9606
75 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
76 4GXV 1 H, I Antibody 1F1, heavy chain 9606
77 4GXV 2 L, M Antibody 1F1, light chain 9606
78 2VXT 1 H MURINE IGG 125-2H 10090
79 2VXT 3 L MURINE IGG 125-2H 10090
80 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
81 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
82 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
83 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
84 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
85 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
86 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
87 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
88 5W24 1 L 5C4 Fab Light Chain 10090
89 5W24 2 H 5C4 Fab Heavy Chain 10090
90 4HPY 1 H CH59 Fab heavy chain 9606
91 4HPY 2 L CH59 Fab light chain 9606
92 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
93 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
94 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
95 4JG1 1 L Fab light chain 9606
96 4JG1 2 H Fab heavy chain 9606
97 6E65 1 L TB31F Fab light chain 9606
98 6E65 2 H TB31F Fab heavy chain 9606
99 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
100 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
101 5VF2 1 A scFv 2D10 10090
102 5I8C 1 A VRC34.01 Fab heavy chain 9606
103 5I8C 2 B VRC34.01 Fab light chain 9606
104 4O5L 1 L Fab F045-092 light chain 9606
105 4O5L 2 H Fab F045-092 heavy chain 9606
106 5MYX 1 A, C Fab c#24 light chain 10090
107 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
108 3IFL 1 L 12A11 FAB antibody light chain 10090
109 3IFL 2 H 12A11 FAB antibody heavy chain 10090
110 5WK2 1 L M116 LIGHT CHAIN 9606
111 5WK2 2 H M116 HEAVY CHAIN FD 9606
112 3PP4 1 H GA101 Fab heavy chain 10090
113 3PP4 2 L GA101 Fab light chain 10090
114 3KDM 1 A, L Immunoglobulin light chain 9606
115 3KDM 2 B, H Immunoglobulin heavy chain 9606
116 5NIV 1 A Light chain of 5D3 Fab 10090
117 5NIV 2 B Heavy chain of 5D3 Fab 10090
118 6UG7 1 L ch28/11 Fab light chain 10090
119 6UG7 2 H ch28/11 Fab heavy chain 10090
120 5N4J 1 L LIGHT CHAIN 9606
121 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
122 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
123 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
124 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
125 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
126 5X4G 1 A 6H8 Fab heavy chain 10090
127 5X4G 2 B 6H8 Fab light chain 10090
128 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
129 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
130 4PTU 1 A Antibody pn132p2C05, light chain 9606
131 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
132 4TPR 1 L If kappa light chain 10090
133 4TPR 2 H Fab heavy chain 10090
134 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
135 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
136 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
137 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
138 3IFN 1 H 12A11 FAB antibody heavy chain 10090
139 3IFN 2 L 12A11 FAB antibody light chain 10090
140 5U3P 1 H DH511.4 Fab Heavy Chain 9606
141 5U3P 2 L DH511.4 Fab Light Chain 9606
142 6BLA 1 H AMM01 Fab Heavy chain 9606
143 6BLA 2 L AMM01 Fab Light chain 9606
144 4TOY 1 H 35O22 Fab Heavy chain 9606
145 4TOY 2 L 35O22 Fab Light chain 9606
146 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
147 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
148 3NPS 2 B S4 FAB HEAVY CHAIN 9606
149 3NPS 3 C S4 FAB LIGHT CHAIN 9606
150 5I4F 1 A scFv 2D10 10090
151 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
152 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
153 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
154 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
155 5WN9 1 H scFv 2D10 9606
156 4XC3 1 L 4E10 Fab light chain 9606
157 4XC3 2 H 4E10 Fab heavy chain 9606
158 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
159 4M5Y 1 H, I Fab 5J8 heavy chain 9606
160 4M5Y 2 L, M Fab 5J8 light chain 9606
161 4TQE 1 L If kappa light chain 10090
162 4TQE 2 H Fab heavy chain 10090
163 5YY4 1 A scFv 4B08 10090
164 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
165 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
166 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
167 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
168 6Q19 1 L Fab lambda chain 9606
169 6Q19 2 H Fab heavy chain 9606
170 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
171 5VSI 2 L CH1/Ckappa Fab light chain 9606
172 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
173 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
174 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
175 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
176 5JXA 1 H VRC03 Heavy chain 9606
177 5JXA 2 L VRC03 Light chain 9606
178 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
179 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
180 6QCU 1 L Light chain 9606
181 6QCU 2 H Heavy chain 9606
182 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
183 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
184 3NTC 1 L Fab light chain 10090
185 3NTC 2 H Fab heavy chain 10090
186 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
187 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
188 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
189 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
190 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
191 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
192 6PZG 1 L NA-80 Fab light chain 9606
193 6PZG 2 H NA-80 Fab heavy chain 9606
194 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
195 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
196 6BE3 1 H Fab (F598) Heavy Chain 9606
197 6BE3 2 L Fab (F598) Light Chain 9606
198 4NWU 1 H APE1551 Ab Fab heavy chain 9606
199 4NWU 2 L APE1551 Ab Fab light chain 9606
200 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
201 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
202 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
203 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
204 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
205 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
206 5EWI 1 H VRC38.01 Heavy Chain 9606
207 5EWI 2 L VRC38.01 Light Chain 9606
208 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
209 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
210 5E2W 1 L AT8 LIGHT CHAIN 10090
211 5E2W 2 H AT8 HEAVY CHAIN 10090
212 5MYK 1 A Fab c#17 light chain 10090
213 5MYK 2 B Fab c#17 heavy chain 10090
214 4NZR 1 H PGT135 heavy chain Fab 9606
215 4NZR 2 L PGT135 light chain Fab 9606
216 5MYO 1 A, C Fab c#6 light chain 10090
217 5MYO 2 B, D Fab c#6 heavy chain 10090
218 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
219 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
220 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
221 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
222 5UEL 1 H 354NC102 Fab Heavy Chain 9606
223 5UEL 2 L 354NC102 Fab Light Chain 9606
224 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
225 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
226 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
227 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
228 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
229 5E2V 1 L AT8 LIGHT CHAIN 10090
230 5E2V 2 H AT8 HEAVY CHAIN 10090
231 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
232 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
233 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
234 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
235 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
236 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
237 5JUE 1 L light chain of UIC2 Fab 10090
238 5JUE 2 H heavy chain of UIC2 Fab 10090
239 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
240 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
241 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
242 5JR1 1 H 10E8 heavy chain 9606
243 5JR1 2 L 10E8 mature light chain 9606
244 6CA7 1 L PCT64_13C light chain 9606
245 6CA7 2 H PCT64_13C heavy chain 9606
246 5VF6 1 A single chain variable fragment 9031
247 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
248 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
249 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
250 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
251 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
252 6MVL 2 H Antibody Fab fragment heavy chain 9606
253 6MVL 3 L Antibody Fab fragment light chain 9606
254 5OB5 2 H fAb Heavy chain 9606
255 5OB5 3 L fAb Light chain 9606
256 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
257 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
258 5I66 1 A 8B6 antibody, heavy chain 10090
259 5I66 2 B 8B6 antibody, light chain 10090
260 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
261 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
262 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
263 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
264 6BZY 1 H 22D11 Heavy Chain 10090
265 6BZY 2 L 22D11 Light Chain 10090
266 3QQ9 1 C, L 101F LIGHT CHAIN 10090
267 3QQ9 2 D, H 101F HEAVY CHAIN 10090
268 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
269 5TKK 3 L mouse antibody vFP5.01 light chain 10090
270 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
271 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
272 5W6C 1 H UCA Fab heavy chain 9606
273 5W6C 2 L UCA Fab light chain 9606
274 5I1K 1 L FAB LIGHT CHAIN 9606
275 5I1K 2 H FAB HEAVY CHAIN 9606
276 3OZ9 1 L Fab NC-1 kappa light chain 10090
277 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
278 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
279 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
280 5V7U 1 L CBTAU-22.1 Fab light chain 9606
281 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
282 5UEA 1 A, H Fab Heavy Chain 9606
283 5UEA 3 B, L Fab Light Chain 9606
284 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
285 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
286 3G5Y 1 A 175 light chain 10090
287 3G5Y 2 B 175 heavy chain 10090
288 5NMV 1 L Fab light chain 10088
289 5NMV 2 H Fab heavy chain 10088
290 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
291 4N8C 2 L, M Light chain of monoclonal antibody 10090
292 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
293 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
294 4HGW 1 A Antibody Fab fragment, light chain 10090
295 4HGW 2 B Antibody Fab fragment, heavy chain 10090
296 1NLB 1 L antibody 19D9D6 light chain 10090
297 1NLB 2 H antibody 19D9D6 heavy chain 10090
298 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
299 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
300 3VFG 1 L 3F8 Light Chain 10090
301 3VFG 2 H 3F8 Heavy Chain 10090
302 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
303 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
304 3QRG 1 L Fab light chain 9606
305 3QRG 2 H Fab heavy chain Fd fragment 9606
306 5M6A 1 A, B, C, D Bence-Jones light chain 9606
307 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
308 4LLY 2 B, D light chain Clambda 9606
309 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
310 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
311 5EZI 1 H Fab c12 heavy chain 9606
312 5EZI 2 L Fab c12 Light chain 9606
313 4K23 1 H anti-uPAR antibody, heavy chain 10090
314 4K23 2 L anti-uPAR antibody, light chain 10090
315 3NCJ 1 L Fab15 Mut8 light chain 9606
316 3NCJ 2 H Fab15 Mut8 heavy chain 9606
317 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
318 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
319 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
320 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
321 5W05 1 L M59 FAB LIGHT CHAIN 10090
322 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
323 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
324 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
325 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
326 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
327 4M61 1 A, C Fab A52 light chain 10090
328 4M61 2 B, D Fab A52 heavy chain 10090
329 5YE3 1 B 2A7D9 VH CH1 chain 10090
330 5YE3 2 A 2A7D9 L chain 10090
331 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
332 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
333 1UM5 1 L Antibody 21H3 L chain 10090
334 1UM5 2 H Antibody 21H3 H chain 10090
335 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
336 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
337 4NWT 1 L APE1531 Ab Fab light chain 9606
338 4NWT 2 H APE1531 Ab Fab heavy chain 9606
339 3WHX 1 A mAb Fab H fragment 10090
340 3WHX 2 B mAb Fab L fragment 10090
341 3NA9 1 L Fab15 light chain 9606
342 3NA9 2 H Fab15 heavy chain 9606
343 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
344 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
345 6RCO 1 A, C R5.004 heavy chain 9606
346 6RCO 2 B, D R5.004 light chain 9606
347 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
348 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
349 4LRI 1 A, B MSL-109 Light Chain 9606
350 4LRI 2 C, P MSL-109 Heavy Chain 9606
351 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
352 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
353 4JN2 1 A, L anti dabigatran Fab 10090
354 4JN2 2 B, H anti dabigatran Fab 10090
355 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
356 4XBE 2 H 4E10 Fab heavy chain 9606
357 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
358 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
359 6BE2 1 H Fab (F598) Heavy Chain 9606
360 6BE2 2 L Fab (F598) Light Chain 9606
361 4JFZ 1 L Fab light chain 9606
362 4JFZ 2 H Fab heavy chain 9606
363 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
364 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
365 3WIF 1 A mAb Fab H fragment 10090
366 3WIF 2 B mAb Fab L fragment 10090
367 5U6A 1 A Light Chain 9606
368 5U6A 2 B Heavy Chain 9606
369 6K0Y 1 A Antibody Heavy Chain 9606
370 6K0Y 2 B Antibody Light Chain 9606
371 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
372 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
373 3MBX 1 L X836 LIGHT CHAIN 10090
374 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
375 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
376 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
377 6APC 1 H Epididymis luminal protein 214 9606
378 6APC 2 L IGL@ protein 9606
379 4HHA 1 A Fab KE5 Fab fragment KE5 9606
380 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
381 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
382 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
383 4RGO 2 H 14G8 heavy chain Fab 10090
384 4RGO 3 L 14G8 light chain Fab 10090
385 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
386 5GRY 1 A, G diabody 9606
387 5UEK 2 H Fab 12E Heavy Chain 9606
388 5UEK 3 L Fab 12E Light Chain 9606
389 3NAA 1 L Fab15 Mut5 light chain 9606
390 3NAA 2 H Fab15 Mut5 heavy chain 9606
391 1Q0X 1 L Fab 9B1, light chain 10090
392 1Q0X 2 H Fab 9B1, heavy chain 10090
393 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
394 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
395 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
396 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
397 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
398 5IK3 2 B, D 1E03 Fab fragment light chain 9606
399 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
400 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
401 5XLI 1 a, b FabL 10090
402 5XLI 2 c, d FabH 10090
403 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
404 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
405 6DC4 1 H Fab AM22 Heavy Chain 9606
406 6DC4 2 L Fab AM22 Light Chain 9606
407 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
408 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
409 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
410 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
411 4WUK 1 H CH65 heavy chain 9606
412 4WUK 2 L CH65 light chain 9606
413 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
414 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
415 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
416 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
417 5JOP 1 D, L Fab 14.22 light chain 10090
418 5JOP 2 E, H Fab14.22 heavy chain 10090
419 4HPO 1 H CH58 Fab heavy chain 9606
420 4HPO 2 L CH58 Fab light chain 9606
421 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
422 5UKN 2 L DH522UCA Fab fragment light chain 9544
423 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
424 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
425 5IT2 1 H heavy chain 9606
426 5IT2 2 L light chain 9606
427 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
428 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
429 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
430 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
431 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
432 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
433 5KVE 2 L ZV-48 Antibody scFv 10090
434 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
435 5MO3 3 L Fab of monoclonal antibody, light chain 10090
436 5GZ0 1 A, C FM329 light chain 1383439
437 5GZ0 2 B, D FM329 heavy chain 1383439
438 6DW2 1 A 6078 Fab light chain 9606
439 6DW2 2 B 6078 Fab heavy chain 9606
440 6MG4 1 A, B JTO light chain 9606
441 6BQB 1 L MGG4 Fab light chain 9606
442 6BQB 2 H MGG4 Fab heavy chain 9606
443 4PUB 1 H DX-2930 HEAVY CHAIN 9606
444 4PUB 2 L DX-2930 LIGHT CHAIN 9606
445 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
446 6B14 2 L Light chain of Fab BL3-6S97N 10090
447 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
448 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
449 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
450 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
451 5GS3 1 A, H diabody protein 9606
452 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
453 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
454 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
455 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
456 5VKD 2 H Fab Heavy Chain 9606
457 5VKD 3 L Fab light chain 9606
458 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
459 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
460 5XHG 1 A, C polypeptide(L) 10090
461 5XHG 2 B, D polypeptide(H) 10090
462 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
463 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
464 3UYR 1 H antibody Fab heavy chain 10090
465 3UYR 2 L antibody Fab light chain 10090
466 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
467 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
468 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
469 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
470 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
471 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
472 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
473 3OAZ 2 K, L Fab 2G12, light chain 9606
474 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
475 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
476 1ZAN 1 L Fab AD11 Light Chain 10116
477 1ZAN 2 H Fab AD11 Heavy Chain 10116
478 6CJK 1 A, C Immunoglobulin Fab light chain 9986
479 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
480 4N0Y 1 H IGH526 Heavy Chain 9606
481 4N0Y 2 L IGH526 Light Chain 9606
482 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
483 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
484 6OTC 2 H sFab H3 heavy chain 32630
485 6OTC 3 L sFab H3 light chain 32630
486 6Q1G 1 L H1244 Fab lambda chain 9606
487 6Q1G 2 H H1244 Fab heavy chain 9606
488 5MTH 1 A, H antibody Fab heavy chain 10090
489 5MTH 2 B, L antibody Fab light chain 10090
490 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
491 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
492 1RZF 1 L Fab E51 light chain 9606
493 1RZF 2 H Fab E51 heavy chain 9606
494 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
495 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
496 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
497 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
498 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
499 4KTE 2 L GE148 Light Chain Fab 9544
500 5I8O 1 H HMM5 antibody heavy chain 9606
501 5I8O 2 L HMM5 antibody light chain 9606
502 4OUO 1 A anti Bla g 1 scFv 9031
503 4JG0 1 L Fab light chain 9606
504 4JG0 2 H Fab heavy chain 9606
505 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
506 4YGV 2 B, L aDabi-Fab2a light chain 9606
507 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
508 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
509 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
510 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
511 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
512 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
513 3EO0 1 A, C GC-1008 Fab Light Chain 10090
514 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
515 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
516 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
517 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
518 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
519 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
520 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
521 4FQI 3 H antibody CR9114 heavy chain Fab 9606
522 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
523 6S5A 2 H anti P329G LALA Fab heavy chain 10090
524 6S5A 3 L anti P329G LALA Fab light chain 10090
525 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
526 4JHA 2 L D25 light chain 9606
527 6B9Z 1 A Trastuzumab Fab light chain 10090
528 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
529 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
530 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
531 4PTT 1 A Antibody pn132p2C05, light chain 9606
532 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
533 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
534 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
535 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
536 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
537 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
538 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
539 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
540 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
541 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
542 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
543 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
544 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
545 4DGV 1 H HCV1 Heavy Chain Fab 9606
546 4DGV 2 L HCV1 Light Chain 9606
547 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
548 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
549 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
550 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
551 5TH2 1 A, C cetuximab Fab, light chain 10090
552 5TH2 2 B, D cetuximab Fab, heavy chain 10090
553 5I8K 1 L HHH1 Fab Light chain 9606
554 5I8K 2 H HHH1 Fab Heavy chain 9606
555 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
556 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
557 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
558 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
559 1YNL 1 L Ig gamma light chain 10090
560 1YNL 2 H Ig gamma heavy chain 10090
561 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
562 5EPM 2 B, F Antibody Fab fragment light chain 10090
563 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
564 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
565 3UMT 1 A scFv heavy chain and light chain 10090
566 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
567 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
568 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
569 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
570 6UC5 1 H Fab397 heavy chain 9606
571 6UC5 2 L Fab397 light chain 9606
572 4NUJ 1 A PGT152 light chain 9606
573 4NUJ 2 B PGT152 heavy chain 9606
574 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
575 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
576 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
577 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
578 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
579 3U2S 2 B, L PG9 light chain 9606
580 6PE7 1 H FAB Heavy Chain 9606
581 6PE7 2 L FAB Light chain 9606
582 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
583 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
584 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
585 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
586 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
587 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
588 4NUG 1 L PGT151 light chain 9606
589 4NUG 2 H PGT151 heavy chain 9606
590 3IU4 1 H chP3 Fab heavy chain 10090
591 3IU4 2 L chP3 Fab light chain 10090
592 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
593 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
594 6DC8 1 L IgG light chain 10090
595 6DC8 2 H IgG heavy chain 10090
596 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
597 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
598 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
599 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
600 6IAS 1 H Fab NKp46-1 heavy chain 32630
601 6IAS 2 L Fab NKp46-1 light chain 32630
602 1P7K 1 A, L antibody light chain FAB 10090
603 1P7K 2 B, H antibody heavy chain FAB 10090
604 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
605 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
606 3RVV 2 C 4C1 - light chain 10090
607 3RVV 3 D 4C1 - heavy chain 10090
608 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
609 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
610 3P0Y 2 H Fab DL11 heavy chain 9606
611 3P0Y 3 L Fab DL11 light chain 9606
612 4NPY 1 A, L germline PGT121 light chain Fab 9606
613 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
614 6ANA 2 H LL2 Fab Heavy Chain 10090
615 6ANA 3 L LL2 Fab Light Chain 10090
616 5IBU 1 B, L 6652 Light Chain 9606
617 5IBU 2 G, H 6652 Heavy Chain 9606
618 5VPL 2 C 4C1 - LIGHT CHAIN 10090
619 5VPL 3 D 4C1 - HEAVY CHAIN 10090
620 6AOD 1 A FXIa Antibody FAB Light Chain 9606
621 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
622 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
623 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
624 2YPV 2 H FAB 12C1 10090
625 2YPV 3 L FAB 12C1 10090
626 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
627 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
628 4JY5 1 L PGT122 light chain Fab 9606
629 4JY5 2 H PGT122 heavy chain Fab 9606
630 6ELE 1 A, H fAB heavy chain 9606
631 6ELE 2 B, L fAB light chain 9606
632 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
633 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
634 6B5R 1 H CIS42 Fab Heavy chain 9606
635 6B5R 2 L CIS42 Fab Light chain 9606
636 3NAC 1 L Fab15 Mut7 light chain 9606
637 3NAC 2 H Fab15 Mut7 heavy chain 9606
638 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
639 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
640 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
641 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
642 1Q72 1 L Fab M82G2, Light chain 10090
643 1Q72 2 H Fab M82G2, Heavy chain 10090
644 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
645 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
646 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
647 6MNQ 3 L Ab DH727.2 light chain 9544
648 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
649 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
650 4YHO 1 H aDabi-Fab3 heavy chain 9606
651 4YHO 2 L aDabi-Fab3 light chain 9606
652 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
653 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
654 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
655 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
656 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
657 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
658 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
659 4DGY 1 H HCV1 Heavy Chain Fab 9606
660 4DGY 2 L HCV1 Light Chain 9606
661 5EN2 1 A GD01 heavy chain 10090
662 5EN2 2 B GD01 light chain 10090
663 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
664 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
665 6P4Y 1 H 4A10 Fab heavy chain 10090
666 6P4Y 2 L 4A10 Fab light chain 10090
667 3MXW 2 L 5E1 light chain 9606
668 3MXW 3 H 5E1 heavy chain 9606
669 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
670 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
671 3EO9 1 L Efalizumab Fab fragment, light chain 9606
672 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
673 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
674 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
675 6N35 1 K, L Fab 2G12 light chain 9606
676 6N35 2 H, M Fab 2G12 heavy chain 9606
677 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
678 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
679 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
680 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
681 5WUV 1 L light chain 9606
682 5WUV 2 H heavy chain 9606
683 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
684 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
685 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
686 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
687 4JM4 1 H PGT 135 Heavy Chain Fab 9606
688 4JM4 2 L PGT 135 Light Chain Fab 9606
689 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
690 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
691 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
692 5YE4 2 B, D 1A9D7 L chain 10090
693 6B0G 1 C 1245 Antibody, Light Chain 9606
694 6B0G 2 D 1245 Antibody, Heavy Chain 9606
695 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
696 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
697 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
698 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
699 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
700 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
701 6D0X 1 A 2140 Antibody, heavy chain 9606
702 6D0X 2 B 1210 Antibody, light chain 9606
703 6BE4 1 H Fab (F598) Heavy Chain 9606
704 6BE4 2 L Fab(F598) Light Chain 9606
705 5TPP 1 L DH270.5 Fab heavy chain 9606
706 5TPP 2 H DH270.5 Fab light chain 9606
707 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
708 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
709 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
710 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
711 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
712 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
713 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
714 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
715 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
716 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
717 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
718 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
719 5TL5 1 L M2177 LIGHT CHAIN 10090
720 5TL5 2 H M2177 HEAVY CHAIN 10090
721 2FX7 1 L Fab 4E10 Light Chain 9606
722 2FX7 2 H Fab 4E10 Heavy Chain 9606
723 6O39 1 A Antibody F2.I Fab, Light chain 9606
724 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
725 5Y9K 1 L belimumab light chain 9606
726 5Y9K 2 H belimumab heavy chain 9606
727 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
728 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
729 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
730 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
731 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
732 6GLW 3 D, L Fab 1D11 - Light chain 9844
733 3WFH 1 A mAb Fab H fragment 10090
734 3WFH 2 B mAb Fab L fragment 10090
735 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
736 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
737 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
738 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
739 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
740 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
741 6GKU 2 H Fab 6F5 - Heavy Chain 9844
742 6GKU 3 L Fab 6F5 - Light chain 9844
743 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
744 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
745 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
746 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
747 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
748 5HI4 3 D, L CAT-2000 FAB light chain 9606
749 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
750 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
751 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
752 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
753 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
754 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
755 3RVW 2 C 4C1 - light chain 10090
756 3RVW 3 D 4C1 - heavy chain 10090
757 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
758 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
759 5XKU 2 B HNIgGA6 light chain 9606
760 5XKU 3 C HNIgGA6 heavy chain 9606
761 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
762 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
763 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
764 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
765 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
766 5HI5 3 D, L CAT-2000 light chain 9606
767 5JO5 1 A, C, E, H 10E8 gHV 9606
768 5JO5 2 B, D, F, L 10E8 gLV 9606
769 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
770 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
771 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
772 5CCK 2 L Antibody 3BC315 Fab light chain 9606
773 6RNN 1 C, L Immunoglobulin light chain 10090
774 6GXX 1 H FAB 1D9 heavy chain 10090
775 6GXX 2 L FAB 1D9 light chain 10090
776 5I76 1 A, C FM318_light_chain 1383439
777 5I76 2 B, D FM318_heavy_cahin 1383439
778 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
779 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
780 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
781 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
782 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
783 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
784 5I18 1 L FAB LIGHT CHAIN 9606
785 5I18 2 H FAB HEAVY CHAIN 9606
786 6QB3 2 X scFv55 9606
787 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
788 4JN1 2 L anti-dabigatran Fab1, light chain 10090
789 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
790 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
791 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
792 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
793 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
794 4G5Z 2 L canakinumab antibody fragment light chain 9606
795 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
796 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
797 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
798 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
799 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
800 2OK0 2 L Fab ED10 light chain 10090
801 2OK0 3 H Fab ED10 heavy chain 10090
802 3SOB 1 L antibody light chain 9606
803 3SOB 3 H antibody heavy chain 9606
804 6UG8 1 L ch28/11 Fab light chain 10090
805 6UG8 2 H ch28/11 Fab heavy chain 10090
806 6B5M 1 H CIS43 Fab Heavy chain 9606
807 6B5M 2 L CIS43 Fab Light chain 9606
808 5AWN 1 H Heavy chain of 3BC176 Fab 9606
809 5AWN 2 L Light chain of 3BC176 Fab 9606
810 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
811 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
812 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
813 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
814 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
815 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
816 5DR5 2 L AbD09097 Fab light chain 9606
817 6MG5 1 A, B Light chain JTO 9606
818 2IH3 1 A FAB Heavy Chain 10090
819 2IH3 2 B FAB Light Chain 10090
820 4KQ3 1 L CNTO3186 light chain Fab 9606
821 4KQ3 2 H CNTO3186 heavy chain Fab 9606
822 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
823 6AQ7 3 L POM6 FAB light CHAIN 10090
824 4JFX 1 A, L Fab light chain 9606
825 4JFX 2 B, H Fab heavy chain 9606
826 3SGE 1 I, L Light Chain 10090
827 3SGE 2 H, J Heavy Chain 10090
828 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
829 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
830 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
831 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
832 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
833 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
834 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
835 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
836 5FHB 1 H Antibody 100 Fab heavy chain 9606
837 5FHB 2 L Antibody 100 Fab light chain 9606
838 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
839 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
840 1JGU 1 L Antibody Light Chain 10090
841 1JGU 2 H Antibody Heavy Chain 10090
842 4I77 1 H Lebrikizumab heavy chain Fab 9606
843 4I77 2 L Lebrikizumab light chain Fab 9606
844 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
845 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
846 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
847 4O4Y 2 H 2095-2 heavy chain 9986
848 5OBF 1 H fAb Heavy chain 10090
849 5OBF 2 L fAb Light chain 10090
850 6QNK 1 A, C FAB light chain 10090
851 6QNK 2 B, D FAB heavy chain 10090
852 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
853 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
854 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
855 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
856 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
857 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
858 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
859 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
860 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
861 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
862 5MHE 1 L Fab-fragment 10090
863 5MHE 2 H Fab-fragment 10090
864 5YFI 1 L Light chain of Fab fragment 10090
865 5YFI 2 H Heavy chain of Fab fragment 10090
866 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
867 4GLR 3 I, K anti-ptau light chain light chain 9031
868 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
869 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
870 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
871 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
872 4HJG 1 A Trastuzumab light chain 9606
873 4HJG 2 B Trastuzumab heavy chain 9606
874 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
875 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
876 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
877 5I30 1 L Fab PL-2 light chain 10090
878 5I30 2 H Fab PL-2 heavy chain 10090
879 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
880 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
881 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
882 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
883 6CT7 1 B, L BIIB054 Fab light chain 9606
884 6CT7 2 A, H BIIB054 Fab heavy chain 9606
885 3FN0 1 L Fab Z13e1 light chain 9606
886 3FN0 2 H Fab Z13e1 heavy chain 9606
887 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
888 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
889 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
890 4YHI 2 B, L aDabi-Fab2a light chain 9606
891 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
892 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
893 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
894 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
895 4OSU 1 H SM5-1 Fab Heavy Chain 9606
896 4OSU 2 L SM5-1 Fab Light Chain 9606
897 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
898 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
899 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
900 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
901 1T2Q 1 L Fab NNA7 Heavy Chain 10090
902 1T2Q 2 H Fab NNA7 Light Chain 10090
903 6ELJ 1 A, H fAB heavy chain 9606
904 6ELJ 2 B, L fAB light chain 9606
905 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
906 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
907 4MAU 1 L C2244 light chain SEE REMARK 999 10090
908 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
909 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
910 3LEX 2 B, L 11f10 Antibody Light Chain 10090
911 6B0W 1 L 1710 antibody, light chain 9606
912 6B0W 2 H 1710 antibody, heavy chain 9606
913 6DC7 1 L, M Fab light chain 10090
914 6DC7 2 H, I Fab heavy chain 10090
915 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
916 5VH4 2 B, L Infliximab Fab Light Chain 10090
917 6NOU 1 A scFv derived from ixekizumab 9606
918 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain